EconomyChina’s pharma stocks gain favour amid ‘greater’ progress in innovative drugs

Chinese pharmaceutical companies are expanding globally, and analysts say the sector could maintain rapid growth as third-quarter earnings arrive, potentially lifting market sentiment further. Domestic innovative drugs made up 80% of innovative medicines approved in China during the first three quarters, according to the Ministry of Industry and Information Technology.

Chinese pharma stocksinnovative drugsglobal expansionthird-quarter earnings

SSouth China Morning Post★★☆☆☆2026-10-21 01:00Original